Detalhe da pesquisa
1.
Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphoma.
Blood
; 135(12): 934-947, 2020 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-31972002
2.
Enhancer profiling identifies critical cancer genes and characterizes cell identity in adult T-cell leukemia.
Blood
; 130(21): 2326-2338, 2017 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28978570
3.
Targeting General Transcriptional Machinery as a Therapeutic Strategy for Adult T-Cell Leukemia.
Molecules
; 23(5)2018 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29724031
4.
IRF4 as an Oncogenic Master Transcription Factor.
Cancers (Basel)
; 14(17)2022 Sep 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36077849
5.
Requirement for TP73 and genetic alterations originating from its intragenic super-enhancer in adult T-cell leukemia.
Leukemia
; 36(9): 2293-2305, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35908104
6.
IRF4 drives clonal evolution and lineage choice in a zebrafish model of T-cell lymphoma.
Nat Commun
; 13(1): 2420, 2022 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35504924
7.
Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma.
Blood Cancer J
; 11(2): 32, 2021 02 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33579893